Workflow
Teladoc(TDOC)
icon
搜索文档
Teladoc(TDOC) - 2022 Q1 - Earnings Call Presentation
2022-04-29 22:14
| --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|---------------------|-------|----------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | Teladoc. HEALTH | | 9 1Q-22 Quarterly Results | | | | Safe Harbor This presentation contains, and our officers may make, "forward-looking" statements that are based on our management's beliefs and assumptions and on information currently available to management. These forward-looking statements inc ...
Teladoc(TDOC) - 2022 Q1 - Earnings Call Transcript
2022-04-28 08:17
Teladoc Health Inc. (NYSE:TDOC) Q1 2022 Earnings Conference Call April 27, 2022 4:30 PM ET Company Participants Patrick Feeley - Head of IR Jason Gorevic - CEO Mala Murthy - CFO Conference Call Participants Lisa Gill - JPMorgan Ryan Daniels - William Blair Sandy Draper - Guggenheim Securities Sean Dodge - RBC Capital Markets Richard Close - Canaccord Genuity Stephanie Davis - SVB Leerink Daniel Grosslight - Citigroup Charles Rhyee - Cowen Jessica Tassan - Piper Sandler Allen Lutz - Bank of America Ge ...
Teladoc(TDOC) - 2021 Q4 - Annual Report
2022-02-28 00:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2021 8i or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37477 TELADOC HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 04-3705970 (State of incorporation) (I ...
Teladoc(TDOC) - 2021 Q4 - Earnings Call Presentation
2022-02-24 01:34
| --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|---------------------|-------|---------------------------|-------|-------|-------| | | | | | | | | | | | | | | Teladoc. HEALTH | | 9 4Q-21 Quarterly Results | | | | Safe Harbor This presentation contains, and our officers may make, "forward-looking" statements that are based on our management's beliefs and assumptions and on information currently available to management. These forward-looking statements include, without limitat ...
Teladoc(TDOC) - 2021 Q4 - Earnings Call Transcript
2022-02-23 09:33
Teladoc Health Inc. (NYSE:TDOC) Q4 2021 Results Conference Call February 22, 2022 4:30 PM ET Company Participants Patrick Feeley - VP, IR Jason Gorevic - CEO Mala Murthy - CFO Conference Call Participants Charles Rhyee - Cowen Daniel Grosslight - Citi David Larsen - BTIG George Hill - Deutsche Bank Jailendra Singh - Credit Suisse Jessica Tassan - Piper Sandler Lisa Gill - JPMorgan Dev Weerasuriya - Berenberg Richard Close - Canaccord Genuity Ryan MacDonald - Needham Ryan Daniels - William Blair Sean Dodge - ...
Teladoc Health (TDOC) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference
2022-01-13 04:43
| --- | --- | --- | |-----------------------------------|----------------------------|-------| | | | | | Teladoc.. HEALTH | 00000000 | | | J.P. Morgan Healthcare Conference | 00000000 00000000 00000000 | | | Jason Gorevic, CEO January 2022 | 00000000 00000000 OOOOOOOO | | This presentation contains, and our officers may make, "forward-looking" statements that are based on our management's beliefs and assumptions and on information currently available to management. These forward-looking statements include, ...
Teladoc(TDOC) - 2021 Q3 - Quarterly Report
2021-11-01 00:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37477 TELADOC HEALTH, INC. (Exact name of registrant as specified in its charter) 2 Manhattanville Road, Suite 203 P ...
Teladoc(TDOC) - 2021 Q3 - Earnings Call Presentation
2021-10-29 02:39
| --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------|---------------|-------|-------|---------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | Teladoc. | | | 9 3Q-21 Quarterly Results | | | | Safe Harbor This presentation contains, and our officers may make, "forward-looking" statements that are based on our management's beliefs and assumptions and on information currently available to management. These forward-looking statements include, without ...
Teladoc(TDOC) - 2021 Q3 - Earnings Call Transcript
2021-10-28 07:51
Teladoc Health, Inc. (NYSE:TDOC) Q3 2021 Earnings Conference Call October 27, 2021 4:30 PM ET Company Participants Patrick Feeley – Head of Investor Relations Jason Gorevic – Chief Executive Officer Mala Murthy – Chief Financial Officer Conference Call Participants Lisa Gill – JPMorgan Sean Wieland – Piper Sandler Jailendra Singh – Credit Suisse Stephanie Davis – SVB Leerink Richard Close – Canaccord Ryan Daniels – William Blair Gwen – Cowen Sean Dodge – RBC Capital Markets Daniel Grasslight – Citigroup Geo ...
Teladoc(TDOC) - 2021 Q2 - Quarterly Report
2021-08-02 00:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37477 TELADOC HEALTH, INC. (Exact name of registrant as specified in its charter) (Registrant's telephone number includin ...